The Influence of Aged Garlic Extract on the Uptake of Saquinavir and Darunavir into HepG2 Cells and Rat Liver Slices

Aungst, 1999, P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs, Adv. Drug Deliv. Rev., 39, 105, 10.1016/S0169-409X(99)00022-8 Reed, 2006, Novel antiretroviral agents in HIV therapy, Curr. infect. dis. rep., 8, 489, 10.1007/s11908-006-0024-6 Lee, 2006, Interactions between natural health products and antiretroviral drugs: pharmacokinetic and pharmacodynamic effects, Curr. infect. dis. rep., 43, 1052, 10.1086/507894 Mills, 2005, Natural health product-HIV interactions: a systematic review, Int. J. STD AIDS, 16, 181, 10.1258/0956462053420103 Foster, 2005, Natural health products and drug disposition, Annu. Rev. Pharmacol. Toxicol., 45, 203, 10.1146/annurev.pharmtox.45.120403.095950 Fugh-Berman, 2001, Herb-drug interactions: review and assessment of report reliability, Br. J. Clin. Pharmacol., 52, 587, 10.1046/j.0306-5251.2001.01469.x Piscitelli, 2002, The effect of garlic supplements on the pharmacokinetics of saquinavir, Clin. infect. dis., 34, 234, 10.1086/324351 Prezista®, Janssen-Cilag Ltd, Summary of product characteristics; http:/emc.medicines.org.uk/. Vermeir, 2009, Absorption, metabolism and excretion of darunavir, a new protease inhibitor, administered alone and with low-dose ritonavir in healthy subjects, Drug Metab. Dispos., 37, 809, 10.1124/dmd.108.024109 Alexandre, 1996, Azimzadeh, A., Nicod, L., Boudjema, K. and Richert, L.: Expression of Cytochromes P-450 2E1, 3A4 and 1A1/1A2 in Growing and Confluent Human HepG2 Hepatoma Cells-Effect of Ethanol, Toxicol. in vitro, 13, 427, 10.1016/S0887-2333(99)00007-7 Hilgendorf, 2007, Expression of Thirty-six Drug Transporter Genes in Human Intestine, Liver, Kidney, and Organotypic Cell Lines, Drug Metab. Dispos., 35, 1333, 10.1124/dmd.107.014902 Berginc, 2009, Aged garlic extract stimulates P-glycoprotein and multidrug resistance associated protein 2 mediated effluxes, Biol. Pharm. Bull., 32, 694, 10.1248/bpb.32.694 Hawkins, 2007, Decreased blood–brain barrier permeability to fluorescein in streptozotocin-treated rats, Neurosci. Lett., 411, 1, 10.1016/j.neulet.2006.09.010 Berginc, 2010, In vitro interactions between aged garlic extract and drugs used for the treatment of cardiovascular and diabetic patients, Eur. J. Nutr., 10.1007/s00394-010-0095-x Williams, 2002, Direct Evidence that Saquinavir Is Transported by Multidrug Resistance Associated Protein (MRP1) and Canalicular Multispecific Organic Anion Transporter (MRP2), Antimicrob. Agents Chemother., 46, 3456, 10.1128/AAC.46.11.3456-3462.2002 Gupta, 2004, HIV protease inhibitors are inhibitors but not substrates of the human breast cancer resistance protein (BCRP/ABCG2), J. Pharmacol. Exp. Ther., 310, 334, 10.1124/jpet.104.065342 Buss, 2001, Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) aministration, Br. J. Clin. Pharmacol., 52, 255, 10.1046/j.0306-5251.2001.01452.x Usansky, 2008, Differential Roles of P-Glycoprotein, Multidrug Resistance-Associated Protein 2, and CYP3A on Saquinavir Oral Absorption in Sprague–Dawley Rats, Drug metab. dispos., 36, 863, 10.1124/dmd.107.017483 Wu, 2005, Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of Biofarmaceutical drug disposition classification system, Pharm. Res., 22, 11, 10.1007/s11095-004-9004-4 Sekar, 2007, The Effect of Different Meal Types on the Pharmacokinetics of Darunavir (TMC114)/Ritonavir in HIV-Negative Healthy Volunteers, J. Clin. Pharmacol., 47, 479, 10.1177/0091270006298603 Drewe, 1999, HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than cyclosporine analog SDZ PSC 833, Biochem. Pharmacol., 57, 1147, 10.1016/S0006-2952(99)00026-X Fujimoto, 2009, P-Glycoprotein Mediates Efflux Transport of Darunavir in Human Intestinal Caco-2 and ABCB1 Gene-Transfected Renal LLC-PK1 Cell Lines, Biol. Pharm. Bull., 32, 1588, 10.1248/bpb.32.1588 Villanueva, 2005, Involvement of Mrp2 in Hepatic and Intestinal Disposition of Dinitrophenyl-S-glutathione in Partially Hepatectomized Rats, Toxicol. Sci., 84, 4, 10.1093/toxsci/kfi053 Payen, 2002, The drug efflux pump MRP-2: Regulation of expression in physiopathological situations and by endogenous and exogenous compounds, Cell Biol. Toxicol., 18, 221, 10.1023/A:1016020626941 Tanaka, 2002, Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice, Am. J. Physiol. Gastrointest. Liver Physiol., 282, G656, 10.1152/ajpgi.00383.2001 Foster, 2001, An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic, J. Pharm. Pharmaceut. Sci., 4, 176